Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022008827 - METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT

Publication Number WO/2022/008827
Publication Date 13.01.2022
International Application No. PCT/FR2021/051229
International Filing Date 05.07.2021
IPC
C12Q 1/6883 2018.1
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
68involving nucleic acids
6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
6883for diseases caused by alterations of genetic material
Applicants
  • BIOMÉRIEUX [FR]/[FR]
  • BIOASTER [FR]/[FR]
  • HOSPICES CIVILS DE LYON [FR]/[FR]
Inventors
  • VACHOT, Laurence
  • MALLET, François
  • MONNERET, Guillaume
  • MOUCADEL, Virginie
  • PACHOT, Alexandre
  • PERONNET, Estelle
  • RIMMELÉ, Thomas
  • TEXTORIS, Julien
  • VENET, Fabienne
Agents
  • CABINET GERMAIN ET MAUREAU
Priority Data
FR200713306.07.2020FR
Publication Language French (fr)
Filing Language French (FR)
Designated States
Title
(EN) METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT
(FR) PROCÉDÉ POUR DÉTERMINER LE RISQUE DE SURVENUE D'UNE INFECTION ASSOCIÉE AUX SOINS CHEZ UN PATIENT
Abstract
(EN) The present invention relates to an in vitro or ex vivo method for determining the risk of a care-related infection in a patient, comprising a step of measuring the expression of at least one gene encoding a pro-inflammatory cytokine receptor, located in the region 2q11-2q12 of chromosome 2 in a biological sample of said patient.
(FR) La présente invention concerne un procédé in vitro ou ex vivo pour déterminer le risque de survenue d'une infection associée aux soins chez un patient, comprenant une étape de mesure de l'expression d'au moins un gène codant pour un récepteur à cytokine pro-inflammatoire, localisé dans le chromosome 2, au niveau de la région 2q11-2q12, dans un échantillon biologique dudit patient.
Latest bibliographic data on file with the International Bureau